Penny Stock Under Rs 30 Hits 5% Back-to-Back Upper Circuit As Company Announces Official Launch of AI Health Platform

The Indian equity markets traded in the green on Monday, with the Nifty 50 index gaining 0.50 per cent to 24,117.35 during the session. Amid the positive momentum in benchmark indices, stock-specific buying action remained strong in select micro-cap technology counters. In this segment, AVI Polymers remained in focus after the company announced the official commercial launch of its flagship AI-powered digital healthcare platform, “AVI Health AI” under the brand name Ashwini.tech. Following the development, AVI Polymers share price was locked in the 5 per cent Upper Circuit at Rs 20.96 on Monday.

AVI Polymers Launches AI-Powered HealthTech Platform

AVI Polymers informed the stock exchanges that its wholly owned technology subsidiary has officially launched Ashwini.tech (AVI Health AI), a personal-healthcare artificial intelligence platform aimed at India’s digital healthcare ecosystem. The company stated that the platform is now live and operational and is designed specifically for India’s mobile-first user base.

According to the investor presentation shared by the company, the platform offers real-time wellness analytics, diagnostic assistance, AI-backed medical timeline creation, medication intelligence, doctor-ready printable packs and family healthcare access through a unified digital health record system. The company has positioned the product as a household personal health record platform built on source-linked AI architecture.

Company Completes Dual AI Ecosystem Strategy

The company stated that with Agritech platform KrishiBuddy already live and scaling, the successful launch of Ashwini.tech completes AVI Polymers’ foundational dual-engine AI strategy across AgriTech and HealthTech. Management said the company is now positioned at the intersection of two high-growth digital markets with immediate FY27 commercialisation plans.

AVI Polymers further stated that this technology deployment has been fully supported by its zero-debt balance sheet and recent capital infusion of Rs 89.99 crore, which the company expects will support ecosystem monetisation and long-term shareholder value creation. The filing also highlighted that the company had already achieved a historic FY26 revenue milestone of Rs 312.11 crore.

Investor Presentation Highlights Commercial Revenue Model

As per the investor note, the company plans to monetise the platform through multiple channels including consumer subscriptions, NRI premium caregiving, doctor pack channel partnerships, insurance white-label integrations, pharma real-world evidence cohorts and ABDM-linked healthcare infrastructure layers. The presentation also highlighted that the product is currently live in private beta and built on a scalable software-led low incremental cost model.

About AVI Polymers 

AVI Polymers Ltd is a listed micro-cap company that has been expanding beyond its traditional polymer business into technology-led AgriTech and HealthTech platforms through its wholly owned subsidiaries. The company is currently focused on building digital AI-enabled scalable ecosystems across high-growth sectors.

Share your thoughts in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.